Trial intelligence / Profile preview

Acute Effects of THC in Older Adults

NCT06948136Phase 1Recruiting

Sponsor
Yale University
Start
Jun 2025
Primary completion
Nov 2027
Modality
Small Molecules
Countries
1
01

Overview

Phase 1 trial of dronabinol in age-related cognitive decline (3 arms), sponsored by Yale University. Primary endpoint: Rey Auditory Verbal Learning Task total immediate recall at 25 minutes. Started Jun 2025; status: recruiting.

02

Drugs

dronabinol
03

Conditions

age-related cognitive decline

Beyond the preview

Go deeper on NCT06948136.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06948136.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call